Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share
CTV.WS
CTV.WS was delisted on the 12th of February, 2025.
19 hedge funds and large institutions have $686K invested in Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share in 2024 Q4 according to their latest regulatory filings, with 7 funds opening new positions, increasing their positions, 2 reducing their positions, and 1 closing their positions.
2,569% more capital invested
Capital invested by funds: $25.7K → $686K (+$660K)
600% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 1
36% more funds holding
Funds holding: 14 → 19 (+5)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LP
LMR Partners
London,
United Kingdom
|
+$85.3K |
| 2 |
PF
Phoenix Financial
Givatayim,
Israel
|
+$56.3K |
| 3 |
MC
Meteora Capital
Boca Raton,
Florida
|
+$12.5K |
| 4 |
BFM
Boothbay Fund Management
New York
|
+$6.25K |
| 5 |
TSS
Two Sigma Securities
New York
|
+$1.25K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UM
Ulysses Management
New York
|
-$903 |
| 2 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
-$23 |
CTV.WS Hedge Fund Activity: Q4 2024 in Review
19 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share (CTV.WS) for Q4 2024, worth a combined $686K — up 2,569% from $25.7K a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new CTV.WS positions and 1 closed out — a net gain of 6 holders — while 0 added to existing stakes and 2 trimmed.
The largest buyer was LMR Partners, opening a new position worth an estimated $85.3K. The largest seller was Ulysses Management, cutting an estimated $903.
- 19 institutional investors held Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share (CTV.WS) as of Q4 2024, up from 14 in Q3 2024.
- Funds reported $686K of Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share stock for Q4 2024, up 2,569% quarter-over-quarter.
- 7 funds opened new Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share positions in Q4 2024 and 1 closed out, a net change of +6 holders.
- The largest Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share buyer in Q4 2024 was LMR Partners, an estimated $85.3K added.
- The largest Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share seller in Q4 2024 was Ulysses Management, an estimated $903 sold.
Based on aggregated 13F filings for Q4 2024.